Abstract
The coronavirus disease 2019 (COVID-19) infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 and represents a great challenge for medical and scientific community nowadays involved with disease elucidation and finding effective treatments and vaccines to control the pandemic. The use of specific antibodies against infectious agents is a stra…